Adenosine Therapeutics LLC: Accounting for a Different Compensation Method

7 Pages Posted: 21 Oct 2008

See all articles by Mark E. Haskins

Mark E. Haskins

University of Virginia - Darden School of Business

Abstract

This case challenges students to apply financial reporting concepts pertaining, most notably, to liabilities and expenses in a specific corporate situation. In the context of an interesting, but noncomplex, technical accounting issue, students debate the best way for Adenosine Therapeutics to present its compensation arrangements in its financial statements. In addition, this case also prompts students to debate the best way for a growing company, with cash constraints, to provide incentive and maintain top employees.

Keywords: accounting, inflation, compensation, employee, financial reporting and disclosure

JEL Classification: M41, M45, J33, A20

Suggested Citation

Haskins, Mark E., Adenosine Therapeutics LLC: Accounting for a Different Compensation Method. Darden Case No. UVA-C-2264, Available at SSRN: https://ssrn.com/abstract=1277001

Mark E. Haskins (Contact Author)

University of Virginia - Darden School of Business ( email )

P.O. Box 6550
Charlottesville, VA 22906-6550
United States
434-924 -4826 (Phone)

HOME PAGE: http://www.darden.virginia.edu/faculty/haskins.htm

Do you have a job opening that you would like to promote on SSRN?

Paper statistics

Downloads
117
Abstract Views
1,000
rank
293,006
PlumX Metrics